SCHOTT Pharma is celebrating its first anniversary as a legally stand-alone company in the field of pharma drug containment solutions and delivery systems. The former pharma division of the SCHOTT…
Investment of 350 million EUR in state-of-the-art research infrastructure is Boehringer Ingelheim’s largest single investment in Germany to date Boehringer Ingelheim strengthens innovation power and development of biopharmaceuticals, which account…